Mesoblast Limited (ASX:MSB)
2.660
-0.090 (-3.27%)
Feb 21, 2025, 4:10 PM AEST
Mesoblast Employees
Mesoblast had 73 employees as of June 30, 2024. The number of employees decreased by 10 or -12.05% compared to the previous year.
Employees
73
Change (1Y)
-10
Growth (1Y)
-12.05%
Revenue / Employee
121.18K AUD
Profits / Employee
-1.81M AUD
Market Cap
3.38B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
CSL Limited | 32,698 |
Pro Medicus | 69 |
Cochlear | 5,097 |
Sonic Healthcare | 42,000 |
Telix Pharmaceuticals | 234 |
Ramsay Health Care | 90,000 |
Ansell | 15,000 |
Regis Healthcare | 11,000 |
Mesoblast News
- 7 days ago - Mesoblast: Ryoncil Approval Overshadowed By Commercial Hurdles - Seeking Alpha
- 8 days ago - Mesoblast Ltd (MESO) Showcases FDA-Approved Ryoncil® at Prestigious Transplantation Conference - GuruFocus
- 8 days ago - Ryoncil® FDA Approval and Market Launch Highlighted at Tandem Transplantation Meetings - GlobeNewsWire
- 22 days ago - Mesoblast reports Q2 results - Seeking Alpha
- 22 days ago - Mesoblast Ltd (MESO) Announces U.S. Launch of Ryoncil® and Strategic Pipeline Developments - GuruFocus
- 22 days ago - Ryoncil® Commercial Launch Update and Product Pipeline - GlobeNewsWire
- 22 days ago - Mesoblast Ltd (MESO) Announces Key Developments and Financial Highlights for Q2 2024 - GuruFocus
- 22 days ago - Appendix 4C Quarterly Activity Report for Quarter Ended December 31, 2024 - GlobeNewsWire